Hepatitis B in an oncology unit.
D000293:Adolescent; D001803:Blood Transfusion; D002353:Carrier State / Q000453:epidemiology; D003428:Cross Infection / Q000635:transmission*; D004196:Disease Outbreaks / Q000453:epidemiology; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D006509:Hepatitis B / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000635:transmission*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006511:Hepatitis B Antigens / Q000302:isolation & purification; D006757:Hospital Units; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications; D008223:Lymphoma / Q000150:complications; D008297:Male; D008396:Maryland; D009196:Myeloproliferative Disorders / Q000150:complications; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D010564:Personnel, Hospital; D011446:Prospective Studies
D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens